enGene Holdings Inc. — Investor Relations & Filings
enGene Holdings Inc. is a clinical-stage biotechnology company developing non-viral gene therapies. The company's proprietary platform is designed for the local delivery of DNA-based immunotherapies directly to mucosal tissues and other organs. Its lead product candidate, EG-70 (detalimogene voraplasmid), is an intravesical therapy being evaluated for the treatment of high-risk, BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapeutic approach aims to stimulate a patient's own immune system to attack tumor cells. By avoiding viral vectors, enGene seeks to create re-dosable genetic medicines that can be administered without the complexities and potential immunogenicity associated with viral-based systems, with the goal of making gene-based treatments more accessible.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 3 | 2023-11-13 | English | |
| SC 13D | 2023-11-13 | English | |
| CURRENT REPORT | 2023-11-09 | English | |
| Director's Dealing 2023 | 2023-11-08 | English | |
| SC 13D | 2023-11-08 | English | |
| SCHEDULE 13G | 2023-11-07 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13659948 | 3 | 2023-11-13 | English | ||
| 13659949 | SC 13D | 2023-11-13 | English | ||
| 13659950 | CURRENT REPORT | 2023-11-09 | English | ||
| 13659952 | Director's Dealing 2023 | 2023-11-08 | English | ||
| 13659951 | SC 13D | 2023-11-08 | English | ||
| 13659953 | SCHEDULE 13G | 2023-11-07 | English | ||
| 13659954 | FORM 4 | 2023-11-02 | English | ||
| 13659955 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659956 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659957 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659958 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659959 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659960 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659961 | Director's Dealing 2023 | 2023-11-02 | English | ||
| 13659962 | OWNERSHIP DOCUMENT | 2023-10-31 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
enGene Holdings Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33225/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33225 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33225 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33225 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33225}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for enGene Holdings Inc. (id: 33225)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.